Reimbursement to Pharmacies for Generic Drugs by Medicare Part D Sponsors
- PMID: 38051277
- PMCID: PMC10698681
- DOI: 10.1001/jama.2023.21481
Reimbursement to Pharmacies for Generic Drugs by Medicare Part D Sponsors
Plain language summary
This study evaluates whether organizations that offer Medicare Part D plans (referred to as Part D sponsors) overpay pharmacies for generic drugs.
Conflict of interest statement
Figures

References
-
- Sunshine in the black box of pharmacy benefits management: Florida Medicaid pharmacy claims analysis. January 27, 2020. Accessed March 3, 2023. https://ncpa.co/pdf/florida-3aa-medicaid-pharmacy-analysis.pdf
-
- Senate Finance Committee . A bipartisan framework for reducing prescription drug costs by modernizing the supply chain and ensuring meaningful relief at the pharmacy counter. April 20, 2023. Accessed June 15, 2023. https://www.finance.senate.gov/imo/media/doc/042023%20SFC%20Framework%20...
-
- Prescription drug plan formulary, pharmacy network, and pricing information files for order. Centers for Medicare & Medicaid Services. Accessed March 21, 2023. https://www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order...
-
- Maine Health Data Organization. Prescription drug transparency report. December 14, 2022. Accessed March 20, 2023. https://mhdo.maine.gov/_pdf/MHDO%20Rx%20Transparency%20Report_221213.pdf
-
- Centers for Medicare & Medicaid Services . Medicare Advantage/Part D contract and enrollment data. Accessed March 21, 2023. https://www.cms.gov/research-statistics-data-and-systems/statistics-tren...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical